Anti-epileptic medications cause side effects that affect quality of life for epileptic dogs, requiring careful monitoring and dose optimization to balance seizure control against welfare costs.
Epilepsy medication side effects create a welfare balance problem that is unique to long-term disease management - the medication that controls a welfare-compromising condition itself imposes welfare costs through side effects. Phenobarbital's hepatotoxicity requires regular monitoring to prevent liver damage that would compromise welfare more severely than the epilepsy. The sedation and cognitive blunting of some anti-epileptic drugs reduce quality of life between seizures. Newer medications with better side effect profiles including levetiracetam provide more welfare-neutral seizure control for some dogs. The optimal welfare outcome requires individualized medication selection and dose optimization that prioritizes quality of life between seizures alongside seizure frequency reduction.